Panacea Biotec Ltd consolidated Q2 FY2021-22 loss at Rs. 53.01 crore

The Board of Directors of Panacea Biotec Limited, at its meeting held today have approved the unaudited Consolidated financial results of the company for the period ended September 30, 2021.

For the quarter ended September 30, 2021(Q2 FY2022), the company's total income was ₹ 234.20 crore, against ₹184.02 crore in the corresponding quarter of the previous year (YoY) and ₹135.68 crore in previous quarter (QoQ).

For the quarter ended September 30, 2021(Q2 FY2022), the company's net profit / (loss) was ₹-53.01 crore, against ₹-19.33 crore in the corresponding quarter of the previous year (YoY) and ₹-57.35 crore in previous quarter (QoQ).

For the quarter ended September 30, 2021(Q2 FY2022), the company's Earnings Per Share (EPS) was ₹-8.65, against ₹-3.16 in the corresponding quarter of the previous year (YoY) and ₹-9.36 in previous quarter (QoQ).

Financials	Q2 FY2022	Q1 FY2022	QoQ % Change	Q2 FY2021	YoY % Change
Total Income	₹ 234.20 crs	₹135.68 crs	72.61%	₹184.02 crs	27.27%
Net Profit	₹-53.01 crs	₹-57.35 crs	7.57%	₹-19.33 crs	174.24 %
EPS	₹-8.65	₹-9.36	7.59%	₹-3.16	173.73%

For the 6 Months period ended September 30, 2021(Half Year Ended FY 2022), the company's total income was ₹369.88 crore, against ₹317.97 crore in the previous year (YoY) (Half Year Ended FY 2021).

The net profit / (loss) was at ₹-110.36 crore for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), compared to ₹-53.46 crore in the previous year (YoY) (Half Year Ended FY 2021).

The Earnings Per Share stood at ₹-18.02 for the 6 Months period ended September 30, 2021 (Half Year Ended FY 2022), against ₹-8.73 in the previous year (YoY) (Half Year Ended FY 2021).

Financials	Half Year Ended FY2022	Half Year Ended FY2021	% Change
Total Income	₹369.88 crs	₹317.97 crs	16.33%
Net Profit	₹-110.36 crs	₹-53.46 crs	106.43%
EPS	₹-18.02	₹-8.73	106.41%

Shares of Panacea Biotec Limited was last trading in BSE at Rs. 181.45 as compared to the previous close of Rs. 190.85. The total number of shares traded during the day was 52756 in over 1828 trades.

The stock hit an intraday high of Rs. 193.65 and intraday low of 181.35. The net turnover during the day was Rs. 9701983.00.

Source : Equity Bulls

Keywords

PanaceaBiotec Q2FY22 H1FY22 ResultUpdate